Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China · Delayed Price · Currency is CNY 12.35
+0.15 (1.23%)
Jun 9, 2026, 3:00 PM CST
SHA:603456 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603456 stock has a consensus rating of "Buy" and an average price target of ¥20.71. The average 1-year stock price forecast is 67.69% higher than the current stock price, while the lowest is ¥17.50 (+41.70%) and the highest is ¥22.40 (+81.38%).
Price Target: ¥20.71 (+67.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:603456 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 5 | 4 | 4 | 3 |
Financial Forecast
Revenue This Year
5.55B
from 5.51B
Increased by 0.80%
Revenue Next Year
5.83B
from 5.55B
Increased by 5.02%
EPS This Year
0.96
from 0.82
Increased by 17.07%
EPS Next Year
1.02
from 0.96
Increased by 6.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.9B | ||
| Avg | 5.6B | ||
| Low | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.9% | ||
| Avg | 0.8% | ||
| Low | -6.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.96 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 17.1% | ||
| Low | - |